Sector ratings Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Equities
002603
CNE1000015S0
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.69 CNY | -2.74% |
|
-0.30% | -2.23% |
| 03-19 | China Approves Raw Material Application for Yiling Pharmaceutical's Type 2 Diabetes Complications Drug | MT |
| 03-04 | Yiling Pharmaceutical Unit Gets Nod to Market Anti-Tumor Drug | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 4.09B | BB | - | |||||||
| 14.47B | A | ||||||||
| 5.58B | BBB | ||||||||
| 5.09B | BB | ||||||||
| 4.06B | - | - | - | - | - | ||||
| 3.37B | - | B | - | - | - | ||||
| 3.12B | - | ||||||||
| 2.58B | - | - | - | - | - | - | - | ||
| 1.95B | - | - | - | - | - | - | - | ||
| 1.74B | - | - | |||||||
| 1.58B | - | - | - | - | - | ||||
| 1.56B | - | - | - | - | - | ||||
| 1.25B | - | - | - | - | - | - | - | ||
| 1.22B | - | - | - | - | - | - | |||
| 1.18B | - | - | - | - | - | - | - | ||
| 1.05B | - | - | - | - | - | - | - | ||
| 1.04B | - | - | - | - | - | - | - | ||
| 1.03B | - | BB | - | - | |||||
| 1B | - | - | - | - | - | - | - | ||
| 882M | A | ||||||||
| Average | 2.89B | BBB | |||||||
| Weighted average by Cap. | BBB |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















